By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

IACTA Pharmaceuticals 

27101 Puerta Real
Suite 240
Mission Viejo  California  92691  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

IACTA Pharmaceuticals was established to develop and commercialize innovative eyecare products. We’re dedicated to treating diseases, advancing technology and improving patient outcomes.

Our lead investigational product, NM133, is a nano-enabled form of cyclosporine A which is being developed for the treatment of dry eye. Using licensed proprietary Molecular Envelope Technology (MET) from the research stage company Nanomerics, Ltd., this unique nanotechnology allows a hydrophobic drug to be encapsulated and delivered to the tissues of the eye with favorable tissue permeation.

We are developing this innovative drug as a new treatment option for patients with dry eye.

YEAR FOUNDED:

2016

LEADERSHIP:

Founder and CEO: Damon Burrows


Key Statistics


Email:
Ownership: Private

Web Site: IACTA Pharma
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
//-->